- Home
- ZLAB vs VIRT Comparison
ZLAB vs VIRT Comparison
Compare ZLAB & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- VIRT
- Stock Information
- Founded
- ZLAB 2013
- VIRT 2008
- Country
- ZLAB China
- VIRT United States
- Employees
- ZLAB N/A
- VIRT N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- VIRT Investment Bankers/Brokers/Service
- Sector
- ZLAB Health Care
- VIRT Finance
- Exchange
- ZLAB Nasdaq
- VIRT Nasdaq
- Market Cap
- ZLAB 3.6B
- VIRT 3.3B
- IPO Year
- ZLAB 2017
- VIRT 2015
- Fundamental
- Price
- ZLAB $34.55
- VIRT $42.54
- Analyst Decision
- ZLAB Buy
- VIRT Hold
- Analyst Count
- ZLAB 4
- VIRT 8
- Target Price
- ZLAB $47.37
- VIRT $37.25
- AVG Volume (30 Days)
- ZLAB 1.0M
- VIRT 787.0K
- Earning Date
- ZLAB 08-05-2025
- VIRT 07-17-2025
- Dividend Yield
- ZLAB N/A
- VIRT 2.26%
- EPS Growth
- ZLAB N/A
- VIRT 142.03
- EPS
- ZLAB N/A
- VIRT 3.46
- Revenue
- ZLAB $418,326,000.00
- VIRT $2,401,575,000.00
- Revenue This Year
- ZLAB $44.07
- VIRT N/A
- Revenue Next Year
- ZLAB $49.13
- VIRT N/A
- P/E Ratio
- ZLAB N/A
- VIRT $12.27
- Revenue Growth
- ZLAB 43.72
- VIRT 43.16
- 52 Week Low
- ZLAB $16.01
- VIRT $21.59
- 52 Week High
- ZLAB $44.34
- VIRT $44.58
- Technical
- Relative Strength Index (RSI)
- ZLAB 49.05
- VIRT 60.02
- Support Level
- ZLAB $36.36
- VIRT $41.17
- Resistance Level
- ZLAB $44.34
- VIRT $42.32
- Average True Range (ATR)
- ZLAB 1.45
- VIRT 0.99
- MACD
- ZLAB -0.16
- VIRT 0.12
- Stochastic Oscillator
- ZLAB 39.20
- VIRT 86.09
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.